Mutual collaboration is key to Korea's successful new drug development

There is mounting consensus in domestic pharmaceutical industry that the breakthrough for better competitiveness of Korean pharmaceutical firms in the global arena is to ensure the efficiency of R&D spending through a closer collaboration between industry, academia and research labs.

Links with partners in academia and industry will strengthen Korea's position on the cutting edge of science ...